HB3097 EnrolledLRB101 00211 KTG 45213 b

1    AN ACT concerning public aid.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 5. The Illinois Public Aid Code is amended by
5adding Section 12-4.52 as follows:
6    (305 ILCS 5/12-4.52 new)
7    Sec. 12-4.52. Prescriber education.
8    (a) The Department of Healthcare and Family Services shall
9develop, in collaboration with a public university that has a
10Doctor of Pharmacy Professional Program and is located in a
11county with a population of more than 3,000,000, a program
12designed to provide prescribing physicians under the medical
13assistance program with an evidence-based, non-commercial
14source of the latest objective information about
15pharmaceuticals. Information shall be presented to prescribing
16physicians by specially trained pharmacists, nurses, or other
17health professionals to assist prescribing physicians in
18making appropriate therapeutic recommendations.
19    (b) The prescriber education program shall consist of 2
20components: a web-based curriculum and an academic educator
21outreach. The program shall contract with clinical pharmacists
22to provide scheduled visits with prescribing physicians to
23update them on the latest research concerning medication usage



HB3097 Enrolled- 2 -LRB101 00211 KTG 45213 b

1and new updates on disease states in an unbiased manner.
2    (c) Education provided under the prescriber education
3program shall include, but not be limited to, disease-based
4educational modules on the treatment of chronic non-cancer
5pain, diabetes, hypertension, hyperlipidemia, respiratory
6syncytial virus, and nicotine dependence. New modules may be
7created periodically as needed and existing module content
8shall be reviewed and updated on an annual or as-needed basis.
9Educational modules provided under the program shall provide
10prescribing physicians with continuing medical education
12    (d) Additional resources provided under the prescriber
13education program shall include, but not be limited to, the
15        (1) a drug information response center available to
16    prescribing physicians that provides thorough and timely
17    in-depth answers to any questions a prescribing physician
18    may have within 48 hours after a question is received; and
19        (2) information on drug utilization trends within
20    individual and group practices.